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Silencing and position-effect (PE) variegation (PEV), 
which is due to integration of viral vectors in hetero-
chromatin regions, are considered significant obstacles 
to obtaining a consistent level of transgene expression in 
gene therapy. The inclusion of chromatin insulators into 
vectors has been proposed to counteract this position-
dependent variegation of transgene expression. Here, we 
show that the sea urchin chromatin insulator, sns5, pro-
tects a recombinant γ-retroviral vector from the negative 
influence of chromatin in erythroid milieu. This element 
increases the probability of vector expression at  different 
chromosomal integration sites, which reduces both 
silencing and PEV. By chromatin  immunoprecipitation 
(ChIP) analysis, we demonstrated the specific binding of 
GATA1 and Oct1 transcription factors and the enrichment 
of hyperacetylated nucleosomes to sns5 sequences. The 
results suggest that this new insulator is able to main-
tain a euchromatin state inside the provirus locus with 
mechanisms that are common to other characterized 
insulators. On the basis of its ability to function as barrier 
element in erythroid milieu and to bind the erythroid 
specific factor GATA1, the inclusion of sns5 insulator in 
viral vectors may be of practical benefit in gene transfer 
applications and, in particular, for gene therapy of eryth-
roid disorders.
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IntroductIon
Retroviral vectors are the most efficient means of stable gene 
delivery into hematopoietic stem cells. However, because of the 
integration into transcriptionally silent chromatin, a significant 
proportion of insertions are subjected to the repressive effects 
of the surrounding chromatin, which are termed chromosomal 
position effects (PEs), with silencing of provirus expression in a 
significant fraction of cells.1 Chromatin PE can also be manifested 
as expression variegation (PEV), wherein, at a given point in 
time, genetically identical cells will show different phenotypes.2,3 
These adverse effects could be overcome to some extent by the 
incorporation of DNA elements into retroviral vectors, such 
as chromatin insulators, that function to establish and delimit 
domains of expression.4–6 These elements, which were first 
described in drosophila and are found in a wide range of organ-
isms, can influence gene expression because of two experimentally 
defined properties, the positional enhancer blocker and barrier. 
The first function allows chromatin insulators to prevent promoter 
enhancer interactions only when placed between the two and, in 
doing so, can shield promoters from the influence of neighbor-
ing regulatory elements. In addition, by acting as barriers against 
the propagation of condensed chromatin, insulators may buffer 
a transgene from chromosomal PE.7 Several studies have shown 
that the inclusion of the characterized cHS4 insulator in recombi-
nant vectors reduces the rate and severity of vector silencing.8–12 In 
addition, recent evidence has suggested that vectors that are insu-
lated with this element may have a lower propensity to perturb 
nearby gene expression.13 Therefore, the use of chromatin insula-
tors is desirable in gene therapy approaches, as they have the abil-
ity to shield transgenes from the negative influence of chromatin, 
along with the potential to avoid insertional mutagenesis. Here, 
we investigated the ability of a new element, which is found in the 
early histone repeating unit of the sea urchin Paracentrotus lividus, 
to protect vector-encoded transgenes from chromosomal PE. We 
have previously identified an enhancer-blocker element of 265 bp, 
which has been termed sns, at the 3′ end of the H2A early histone 
gene that displays the capability to block enhancer-activated tran-
scription in a polar and directional manner in both sea urchin and 
human cells.14–16 This element functions as an enhancer blocker in 
erythroid milieu and binds erythroid and ubiquitous transcription 
factors.17 Recently, studies in transgenic sea urchin embryos dem-
onstrated that a 462 bp sequence, named sns5, that includes the 
sns sequence is necessary to regulate the transcription of the H2A 
early histone gene during sea urchin development, which suggests 
that the longer sns5 sequence constitutes one of the borders of this 
transcription unit.18 In light of these results, we have investigated 
the ability of both sns and sns5 elements to prevent silencing and 
PEV on the expression of a γ-retrovirus vector. For this purpose, 
we have generated a large panel of mouse erythroleukemia (MEL) 
cells that bear integrated murine stem cell virus-based vectors 
that are flanked by insulators and are followed by the expression 
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of a reporter-GFP gene. We found that sns5, but not sns, exhibits 
boundary properties when flanking the vector in a forward orien-
tation. In order to better understand the mechanism that underlies 
the protection that is afforded by the sns5 chromatin insulator in 
the setting of recombinant-viral vectors, we also used chromatin 
immunoprecipitation (ChIP) experiments to investigate the tran-
scription factors and epigenetic modifications that are localized to 
the sns5 insulator and the downstream long terminal repeat (LTR) 
promoter sequences. We show the colocalization of GATA1 and 
OCT1 transcription factors and the hyperacetylated nucleosomes 
to the sns5 insulator, which suggests that this element is able to 
modify nucleosomal histones in order to maintain a euchromatic 
state inside the provirus locus.
results
construction and characterization of reporter vectors
The maps of the DNA constructs that were used in these  studies 
are shown in Figure 1. All constructs were derived from the 
stem cell retroviral vector, MGPN2.19 We insulated the retroviral 
transgenes by inserting different DNA fragments into the vector 
3′-LTR. PCR and sequence analysis on several transduced clones 
demonstrated that the inserted fragments were faithfully copied 
into the 5′-LTR after the retroviral replication (data not shown). 
The boundary properties of both sns and sns5 were compared to 
that of the characterized 1.2 kb HS4 chromatin insulator from the 
chicken β-globin locus. As controls, the insulators were replaced 
by two spacers of different lengths (270 or 564 bp long) that were 
derived from λ-phage DNA. The inclusion of these various inserts 
had no significant effects on vector titer (Table 1) and stability, as 
shown by the appropriate size of provirus band in the Southern-
blot analysis of selected (G418R NIH-3T3) and unselected (MEL) 
individual clones (data not shown).
Frequency of vector expression in nIH-3t3  
and Mel cells
In a preliminary analysis, we assessed the influence of the sea 
urchin elements sns and sns5 in NIH-3T3 cells. G418 resistant 
clones (25–30 for each vector) from the higher dilution that 
was used for titration (to ensure low-copy integration) were 
expanded for 1 week, and the percentage of GFP+ cells was mea-
sured by flow cytometry. We found a mean value of 56.8% ± 25.5 
for the MGPN2 vector, 56.1% ± 23.8 for the sns (S) vector, and 
68.9 ± 13 for the sns5 (S) vector. These data indicated that the 
inclusion of the sns5 element determined a higher mean percent-
age of GFP-expressing cells within the individual clones with a 
minor grade of variegation among clones as revealed from the 
minor value of SD. In light of this evidence, we switched to MEL 
cells, which have more pronounced vector silencing. In these 
experiments, the expression of the transgene was studied with-
out selection to avoid any bias toward those subsets that are 
permissive for a threshold expression level, which are compat-
ible with drug resistance.20 MEL cells were transduced with the 
uninsulated and insulated vectors (Figure 1) using sets of eco-
tropic producer clones with similar vector titers, and they were 
subsequently cloned in a  limiting dilution assay. Transductions 
were carried out at a modest  multiplicity of infection in order 
to minimize the provirus copy number that was determined by 
Southern-blot analysis (data not shown). A large panel of MEL 
clones, which consisted of >600 unselected clones for each vector, 
derived from two independent transductions, was screened for 
vector integrants by multiplex PCR analysis using NEO specific 
primers for vector detection and mouse β-globin gene specific 
primers, as control. Flow cytometric  analysis was performed for 
GFP expression in PCR+ clones. For each vector, the percent-
age of clones that expressed the transgene was determined by 
considering positive clones to be those that have >5% fluores-
cent cells. The results have shown that the inclusion of the sns5 
element in a forward orientation increased the fraction of GFP-
expressing cells to 85.8 ± 1.4%, as compared to the 45.2 ± 5.9% 
(P = 0.01) obtained with the uninsulated vector and the 56 ± 
1.6% (P = 0.13) obtained with sns5 in reverse orientation. The 
inclusion of the 1.2 kb cHS4 insulator in a forward  orientation 
increased  retroviral expression to 72.4 ± 6% (P = 0.04), which is 
MGPN2 vector 5-LTR 3-LTREGFP pPGK NEO
















270 bp spacer vector
564 bp spacer vector
sns (S) vector
Figure 1 Vector constructs. The control vector MGPN2 based on the 
oncoretrovirus vector murine stem cell virus, contains two reporter 
 cassettes: the GFP gene transcribed from the virus 5′-LTR promoter 
and the NEO gene transcribed from the Pgk promoter. The insulated 
 versions of this vector were constructed by inserting different DNA frag-
ments into the 3′-LTR. In this location, the inserts are copied into the 
5′-LTR to  generate a flanking double copy as indicated by the dashed 
lines. The 462 bp DNA fragment sns5, from the 3′ end of the sea urchin 
H2A early histone gene, was inserted in forward and reverse orienta-
tion to the viral transcription to generate sns5 (S) and sns5 (R) vectors, 
respectively. Analogously, sns (S) and sns (R) vectors were generated by 
inserting the 265 bp sns element. The cHS4 vector contains the 1.2 kb 
HS4 insulator element from the chicken β-globin locus in forward orien-
tation. Two fragments of 270 bp and 564 bp from λ-phage DNA were 
inserted to generate the 270 and 564 bp vectors, respectively. LTR, long 
terminal repeat.
table 1 reporter vector titers
Vector titera
MGPN2 4–7 × 105
sns (S) 2–5 × 105
sns (R) 3–6 × 105
sns5 (S) 2–5 × 105
sns5 (R) 3–5 × 105
cHS4 1–3 × 105
Spacer 270 bp 3–7 × 105
Spacer 564 bp 2–4 × 105
aRange of vector titers of 10–15 GP+E86 producer clones expressed as G418R 
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a result that is similar to that reported by others using the same 
cHS4-insulated vector.9 The sns (S) vector, sns (R)  vector, 270 bp 
spacer vector, and 564 bp spacer vector did not show any sta-
tistically relevant effect on the frequency of expression (49.3 ± 
11.5%, P = 0.69; 43.5 ± 6.5%, P = 0.82; 50.2 ± 3.2%, P = 0.40; and 
50.03 ± 4.7%, P = 0.46, respectively). Detailed results are shown 
in Table 2. These results suggested that the presence of the sns5 
element, similar to the cHS4 element, increased the likelihood of 
the integrated retrovirus transgene to be expressed at  different 
chromosomal positions. To further evaluate the ability of sns5 
to protect  vector transgenes from the initial silencing effect, 
we measured the number of silenced proviruses 72 hours after 
 transduction. We performed cell sorting experiments to separate 
cells that were expressing (GFP+) and not expressing (GFP−), 
the reporter gene, and determined the vector copy number per 
cell (VCN/cell), in both the positive and negative fractions. We 
found that a great number of uninsulated (MGPN2) provirus 
copies were silenced (average of 3.6 VCN/cell), whereas only 0.1 
VCN/cell was detected in the GFP− cells that were transduced 
with both the sns5 (S) and cHS4 vectors. A mean of 0.6 VCN/cell 
and 3.5 VCN/cell was present in the sns5 (R) and the sns (S) trans-
duced cells, respectively (Figure 2). These results demonstrated 
the capability of the sns5 element to improve the probability of 
vector expression in random integration sites and demonstrated 
that this element, like other insulators,9 appears to function in the 
forward orientation only. Chromatin PE can also be manifested 
as PEV, wherein the progeny of a single cell can be affected by the 
spreading of the surrounding chromatin, which leads to a mosaic 
expression pattern.21 To study the PEV, we expanded the GFP+ 
pools of cells and measured the percentage of GFP+ cells twice a 
week for 2 months. The analysis revealed a drop in the fraction 
of cells that were expressing the LTR→GFP cassette for all vec-
tors during the first week of growth (Figure 3). The percentage of 
GFP+ cells remained stable during the subsequent 50 days. The 
expression variegation that was detected within the first week of 
cell growth was quite different for the sns5 (S) and cHS4 vectors 
when compared to the MGPN2, sns (S) and sns5 (R) vectors. In 
particular, the reduction of GFP+ cells was 10% for sns5 (S), 16% 
for cHS4, 52% for MGPN2, 40% for sns5 (R), and 35% for sns (S). 
Together, these data indicated that the sns5 (S) and cHS4 insula-
tors are both able to counteract the silencing of the integrated 
transgene immediately after transduction and during the first 
week of cell expansion. After that time, the extent of variegation 
did not change greatly in both insulated and uninsulated vectors, 
which suggested that most of the epigenetic modifications on the 
integrated transgene have already happened by that time and are 
subsequently inherited by the progeny. The PEV was also evalu-
ated at the clonal level, 30 days after transduction, by measuring 
the percentage of GFP+ cells in the progeny of cells that carried 
one or two provirus copies. A mean value of 13.1 ± 6.7% GFP+ 
cells was found in clones that bore one copy of the uninsulated 
vector. Comparable values were detected in clones that were 
transduced with sns (S) (16 ± 9.2%) and sns5 (R) (18.2 ± 12.2%) 
vectors. A higher percentage of GFP+ cells was reported in the 
progeny of cells bearing a single copy of sns5 (S) vector and cHS4 
vector (79.9 ± 16.2% and 54.3 ± 25.7% respectively), with P < 0.05 
(Figure 4). These results showed that the sns5 insulator improved 
the likelihood of vector expression by counteracting both the ini-
tial silencing and the expression variegation. To confirm that the 
majority of sns5 insulated provirus  copies were transcriptionally 
active, the fluorescence intensity (MFC  values) of each clone was 
plotted against the number of integrated  transgenes. The results 
showed a direct correlation between the level of expression and 
table 2 Frequency of GFP expression in uninsulated and insulated 
vectors
Vector % GFP+/Pcr+a Vcn/cellb
MGPN2 49.4 1.4
41.0 1.4
sns (S) 57.4 1.1
41.2 0.9
sns (R) 39.0 0.9
48.1 1.3
sns5 (S) 86.8 0.8
89.8 1.1




Spacer 270 bp 52.5 1.2
47.9 1.1
Spacer 564 bp 46.7 1
55.4 1.3
Abbreviations: GFP, green fluorescent protein; VCN, vector copy number.
aPercentage of the clones that express the reporter gene (GFP gene) in clones 
that are PCR+ for provirus-specific sequences. bVCN per cell determined by 
Southern-blot analysis.
Vectors MGPN2
6 3.6 4 0.1 4 0.1 4 0.6 7 3.5 2 4
+ + + + +− − − − −




Figure 2 Quantification of gene transfer rates by southern-blot analysis. Southern-blot analysis was performed on genomic DNA from sorted 
GFP+ and GFP− cells transduced with uninsulated and insulated vectors. DNA was digested with EcoRV restriction enzyme, which cuts once in each 
viral long terminal repeat, and the blot was hybridized contemporarily with specific the proviral probe (NEO sequence) and the specific mouse endog-
enous εy globin probe. The DNA from untransduced cells was used as negative control. The band intensities were quantified with a phosphoimager, 
and provirus signals normalized with the εy endogenous globin gene. DNAs from two clones bearing two copies (K1) and four copies (K2) of the 
provirus were loaded as a control for probe-binding efficiency. Vector copy number per cell (VCN/cell) is indicated at the bottom of each line.
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the VCN in cells that were transduced with the sns5 (S) insulated 
vector (slope value: 0.52; r value: 0.89) and, to a lesser degree, 
with the cHS4 insulated vector (slope value: 0.22; r value: 0.54). 
No  significant correlation was observed with any of the other 
vectors (MGPN2 vector, slope: 0.13; r value: 0.46; sns5 (R)  vector, 
slope: 0.06, r value: 0.41; sns (S) vector, slope: 0.051, r value: 0.37) 
(Figure 5). This analysis confirmed that all the vectors tested, 
except those that were insulated with sns5 (S) and cHS4, are 
highly susceptible to transcriptional silencing that is indicated 
by a low transcription level, despite multiple integration events. 
These data also revealed that the mean level of GFP gene expres-
sion among clones containing one copy of vector did not vary 
significantly between the various vectors that were tested, which 
suggested that these chromatin insulators do not have stimula-
tory or inhibitory effects on their own.
transcription factors mapping and chromatin 
architecture of the sns5 insulated vector
In order to elucidate the mechanism by which the sea urchin sns5 
insulator improves the expression of integrated transgene in MEL 
cells, we performed ChIP analysis on three GFP+ and two GFP− 
clones that each carried a single copy of the sns5 (S) vector. The 
integrated vectors were checked for the absence of mutations by 
sequencing overlapping PCR fragments that covered from the 
5′-LTR to the GFP gene (data not shown). Initially, we assessed 
the effective association in vivo of the erythroid GATA1 and the 
ubiquitous Oct1 transcription factors that were previously demon-
strated to bind sns5 in vitro.17 Previous EMSA analysis had shown 
two GATA1 binding regions in the sns5 element, which were in 
a sequence that is common to both the sns5 and sns fragments17 
and a sequence that is located at the 3′ end of sns5 fragment, 
which is not included in the shorter sns element (data not shown). 
Soluble chromatin samples were incubated with anti-GATA1 
and anti-Oct1 antibodies. The specifically immunoprecipitated 
DNA was analyzed by quantitative real-time PCR on the same 
amount of immunoprecipitated and nonimmunoprecipitated 
(input) chromatin using Taqman probes for the sns5 and 5′-LTR 
vector sequences. We found a mean of eightfold enrichment of 
the sns5 sequence in the immunoprecipitated chromatin using 
both antibodies in GFP+ clones (8.4 ± 2.3 for GATA1 and 8.4 ± 
0
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Figure 3 extinction of GFP expression after cell sorting. The GFP+ 
sorted fractions from mouse erythroleukemia cells transduced with the 
uninsulated (MGPN2) and insulated vectors (cHS4 vector, sns5 (S) vec-
tor, sns5 (R) vector, and sns (S) vector) were analyzed by flow cytometry, 
determining the percentage of GFP+ cells twice a week for 60 days. The 
percentages of GFP+ cells are shown on the y-axis and days of analysis 
on the x-axis.
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Figure 4 Percentages of GFP+ cells in individual mouse erythroleu-
kemia clones. The frequency of fluorescent cells was measured, 30 days 
after cell expansion, in individual clones bearing one or two copies of 
vector. In this analysis, 11–15 clones carrying one copy (white bars) and 
18–24 clones carrying two copies (gray bars) of proviruses are included. 
The diagram represents the mean of GFP+ cell percentages ± SD.
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Figure 5 effect of insulators on copy-number dependent expression. 
To check for a potential copy-number dependent effect after 30 days of 
cell expansion the mean fluorescent channel (MFC) values (y-axis) of the 
clones that contain uninsulated or insulated vectors were plotted with 
the number of integrated vectors (x-axis). The analysis were performed 
in clones bearing single or multiple integrated events with a minimum of 
six clones for each group. Linear regression analysis was used for statisti-
cal evaluation. VCN, vector copy number.
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1.8 for Oct1) (Figure 6a). Little or no enrichment was detected 
for both transcription factors in transcriptionally inactive cells 
(0.5 ± 0.8 for GATA1 and 2.8 ± 1.3 for Oct1). As expected, little 
or no enrichment was observed in the LTR promoter region in 
both GFP+ and GFP− clones, because no consensus motifs for 
GATA1 and Oct1 transcription factors are present in the retro-
viral LTR sequences. Next, we sought to determine some histone 
modifications that mark active and inactive chromatin in sns5 
and in downstream viral promoter sequences. By using commer-
cially available specific antibodies, we studied the levels of histone 
H3 acetylation of lysine9 (H3K9ac), which is considered to be a 
key indicator of an “open” chromatin histone code,22 and of his-
tone H3 trimethylation of lysine4 (H3K4me3), which is another 
marker of euchromatin. The levels of H3 dimethylation of lysine9 
(H3K9me2) and the recruitment of MeCP2 to methylated CpG 
dinucleotides were also analyzed as markers of inactive chromatin 
(Figure 6b). Remarkably, in the chromatin of GFP+ clones, sns5 
sequences were highly enriched for H3K9 acetylated nucleosomes 
when compared to the LTR promoter (12.9 ± 2.1-fold in sns5 ver-
sus 4.7 ± 0.8-fold in LTR). In the GFP− clones, a lower enrichment 
of this histone modification was observed (7.1 ± 1.6-fold in sns5 
versus 1.2 ± 0.7-fold in LTR). The histone H3 trimethylation of 
lysine4 was highly represented in the LTR promoter of positive 
clones when compared to the inactive clones (13.6 ± 1.6-fold ver-
sus 5.3 ± 1-fold). Intriguingly, comparable levels of this marker 
were found in sns5 sequences in both the active and inactive 
clones (approximately eightfold enrichment). In GFP− clones, 
the dimethylation of the H3K9 nucleosomes (sns5 4.7 ± 1.3-fold; 
LTR 5.7 ± 0.7-fold) was more relevant, and the recruitment of the 
CpG methylation is specific to the MeCP2 protein in the insula-
tor (8 ± 0.9-fold) and LTR (2.9 ± 0.8-fold). Conversely, the levels 
of H3k9me2 and MeCP2 were undetectable for both sequences 
in the GFP+ clones. Taken together, these results correlate with 
previous large-scale and genome-wide studies, which showed a 
high prevalence of H3K4me3 and H3K9ac-modified nucleosomes 
that were in close proximity to the transcription start sites and 
promoter regions of actively transcribed genes.23–25 These results 
also correlate with other studies that have shown that chromatin 
insulators provide a center for histone acetylation.4,26,27 In conclu-
sion, sns5 is capable of binding transcription factors and hyper-
acetylated nucleosomes, which are properties that are common to 
other well-characterized insulator elements.
dIscussIon
Retroviral-vector integration into heterochromatin regions can 
result in both the loss of transgene expression (PE) and the pro-
cess of PEV. The incorporation of chromatin insulators should 
limit the spread of heterochromatin, which would allow the gene 
to be expressed in almost all cells irrespective of integration site. 
When considering vector-mediated gene therapy, this bound-
ary property is useful to limit the number of integrants per cell 
necessary to achieve therapeutic effects, and to decrease the risk 
of insertional mutagenesis. The enhancer-blocking function may 
also have safety implications. It has been shown that RV and LV 
vectors have preferential intergenic/intragenic integration sites 
and that vector enhancers can activate cellular genes28–30 as well 
as cause insertional mutagenesis events, as reported in some gene 






































































Figure 6 sns5 recruits trans-acting factors and increases provirus histone acetylation and other markers of active chromatin in vivo. ChIP analysis 
was performed in single-copy vector clones using antibody against GATA1 and Oct1 transcription factors (a) and antihistone modifications (b). Mouse 
erythroleukemia cells transduced with sns5 (S) vector were subcloned and scored for the presence of provirus by PCR and for GFP gene expression. PCR+ 
clones (GFP+ and GFP− clones) were analyzed by Southern blotting for vector copy number and integrity. Clones were checked for the “double-copy” 
configuration and fidelity of retrotranscription process by sequencing of PCR fragment. ChIP analysis was performed on chromatin from three positive 
and two negative clones. Soluble chromatin, digested by micrococcal DNase to an average size of 200–600 bp, was immunoprecipitated with antibodies 
against GATA1 and Oct1 transcription factors and with antibodies against histone modifications marking open chromatin (H3K4me3), and (H3K9ac). 
Antibodies against the H3K9me2 and MeCP2 were used as markers of inactive chromatin. Immunoprecipitated DNA was quantitatively analyzed by 
real-time PCR using primers specific for sns5 sequences (white bars) and for the LTR promoter region (black bars). The ratio between the amount of 
 provirus-specific template before and after chromatin immunoprecipitation was determined by quantitative PCR in the same amount (5 ng) of  chromatin. 
Histograms represent the average enrichment values ± SD (y-axis) of at least three independent ChIP experiments for each clone in which PCR was 
 performed twice (in triplicate). In x-axis are represented the antibodies used. ChIP, chromatin immunoprecipitation; LTR, long terminal repeat.
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has been shown to alleviate PEV when flanking integrated trans-
genes, even if it is also reported that this element works best in the 
context of globin genes and may not be as effective at “insulating” 
nonerythroid genes.8,33,34 Here, we report the ability of a new chro-
matin insulator, sns5, from the sea urchin Paracentrotus lividus 
H2A early histone locus, to improve retroviral encoded transgene 
expression in murine erythroid milieu. We found that flanking 
the recombinant retroviral vector, MGPN2, with the sns5 element 
reduced the rate and the severity of positional effects on vector 
transcription. We first demonstrated that the inclusion of the sns5 
element did not affect vector titer and stability, which are crucial 
prerequisites for its use with retrovirus vectors. The likelihood of 
vector expression was investigated in MEL cells by avoiding selec-
tion based on transgene expression that can influence the degree 
of chromosomal PE. By limiting dilution assays, we showed that 
the sns5 chromatin insulator, when flanking the transcription 
unit in a forward orientation, improved the likelihood of trans-
gene expression, as it almost doubled the percentage of cells that 
expressed the vector. Further analysis that was performed in GFP+ 
and GFP− fractions after transduction and during cell expansion 
allowed us to demonstrate that the sns5 element is able to counter-
act the initial silencing and the extinction of expression. In fact, in 
the GFP sorted negative fraction, we found multiple copies of the 
uninsulated provirus per cell as opposed to only 0.1 copies per cell 
of the sns5 insulated provirus, which suggested that a significant 
number of uninsulated provirus copies are silenced immediately. 
Following the extinction profile of the LTR→GFP expression cas-
sette in GFP-expressing cells, it was evident that further copies of 
the uninsulated provirus were silenced later, within the first week, 
as the percentage of GFP-expressing cells dramatically decreased 
at that time. That the sns5 element was able to counteract PEV 
is also evident at the clonal level, as individual clones that con-
tained single integrants showed that the majority of cell progeny 
expressed the transgene after 30 days of cell expansion, whereas 
the expression of the uninsulated vector was highly variegated 
at the same time point. The results obtained in NIH-3T3 cells 
indicate that sns5 (S) also increases the probability of transgene 
expression within cell progeny of individual clones in noneryth-
roid cells. The boundary activity of sns5 is confirmed by a direct 
correlation between the level of GFP expression and VCN. We 
had previously reported that the 265 bp sns5 core element, named 
sns, displayed enhancer-blocking activity in both orientations in 
erythroid milieu.17 The results reported here indicate that sns5, but 
not sns, confers full insulator activity, which suggests that the two 
properties of enhancer blocking and PE protection map to dif-
ferent sequences within this element, as already demonstrated for 
other insulators.35 The boundary activity of sns5 probably involves 
structural aspects and/or redundancy of proteins; in fact in the 
additional 200 bp of sns5, we detected by EMSA a second bind-
ing site for GATA1 factor. Incoming experiments will elucidate 
these aspects. To better understand the mechanisms that underlie 
the protection against PE that are afforded by the sns5 sea urchin 
insulator, we analyzed the in vivo binding of transcription factors 
and the epigenetic modification that marks active and inactive 
chromatin. By ChIP analysis, we showed the specific binding of 
the erythroid GATA1 and the ubiquitous Oct1 transcription fac-
tors and the recruitment of hyperacetylated nucleosomes in the 
insulator sequences of the transcriptionally active provirus. These 
findings are in line with previously suggested insulator mecha-
nisms of action. It is known that insulators alter the structure of 
chromatin by affecting the covalent modifications of histones, 
which has been demonstrated in both yeast and vertebrate cells. 
These studies led to a model in which the boundary of the silenced 
region is determined by a dynamic equilibrium between histone 
deacetylation activity that originates from the heterochromatin 
and histone acetylation activity that is centered on the barrier ele-
ment. The barrier activity of the native cHS4 element is associ-
ated with a peak of histone hyperacetylation and other hallmarks 
of an “open” histone code, which in turn is thought to prevent 
the invasion of transcriptionally repressive heterochromatin from 
an adjoining region into the chicken β-globin locus.26 It has been 
recently shown that the increase in the likelihood of expression of 
a reporter gene in a cHS4-insulated γ-retrovirus vector was cor-
related with an increase in histone H3 acetylation, which peaked 
at the insulator sequences.27 Similar results are reported in this 
study, which has shown a 13-fold enrichment in the level of his-
tone H3K9ac in the sns5 sequence versus a 4.7-fold enrichment in 
the downstream LTR promoter sequences. It is also known that 
transcription factors may contribute to blocking heterochroma-
tin propagation through the recruitment of histone-modifying 
complexes, such as histone acetylases.36,37 The erythroid tran-
scription factor GATA1 was reported to be required to establish 
a tissue-specific histone acetylating pattern by interacting with 
the acetyl-transferase CBP/P300, which mediates changes in his-
tone acetylation.38,39 Our findings of colocalization in the insulator 
sequences of GATA1, other transcription factors, and acetylated 
nucleosomes have significant implications for the conservation of 
insulator function in evolutionary distant organisms, which sug-
gests that this new insulator is able to maintain a euchromatin 
state inside the proviral locus with mechanisms that are common 
to other characterized insulators. Other epigenetic modifications 
that are associated with active chromatin, such as H3K4me3, are 
present in the transcriptionally active provirus, whereas mark-
ers of silent chromatin, such as H3K9me2 and the recruitment 
of MeCP2 to methylated CpG dinucleotides, are undetectable. 
Further experiments are necessary to better outline the role of 
these factors in reducing chromosomal PE on integrated vector 
transcription. The relatively small size of the sns5 insulator should 
simplify modifications of vectors and make some constructions 
possible, where the total length of the insert should be limited. The 
capability to improve the likelihood of retroviral-vector expres-
sion in erythroid cells could be of great interest for its poten-
tial application in gene therapy of erythroid disorders, such as 
β-thalassemia.
MaterIals and MetHods
Retrovirus vectors. The retrovirus-vector constructs, which are shown 
in Figure 1, were generated by using the murine stem cell virus vector, 
MGPN2.40 This vector contains the viral LTRs, the extended packaging 
signal from the murine stem cell virus that expresses the GFP gene from 
the viral 5′-LTR promoter (LTR→GFP cassette) and the Neo gene from 
a Pgk promoter (Pgk→Neo cassette).41 The recombinant vectors were 
designed by inserting different DNA fragments into the Not1-restriction 
site of the multiple cloning site, which were previously inserted into the 
Nhe I site at the 3′-LTR of the original MGPN2 vector. From this location, 
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the insulator fragments are copied into the 5′-LTR during provirus inte-
gration in order to generate a flanking “double-copy” configuration.42 To 
generate sns (S) and sns (R) vectors, a 265 bp HpaII-Sau3A sns fragment, 
which was from the subclone of pH70 histone DNA,43 was cloned into 
the pGEM T-easy plasmid, cut with the Not1-restriction enzyme and 
inserted into the 3′-LTR in both orientations with respect to virus tran-
scription. The sns5 (S) and sns5 (R) vectors were constructed similarly 
by inserting a Not1-462 bp-sns5 fragment from the H2A-CAT-sns5 plas-
mid.18 As a control, spacer DNAs of comparable sizes from λ-phage DNA 
were cloned into the same position, which generated the 270-spacer 
vector and the 564-spacer vector. The cHS4 vector, which contains the 
1,203 bp XbaI fragment from the chicken β-globin locus inserted in 5′–3′ 
orientation at the Nhe I site of the LTR, was kindly provided by D.W. 
Emery (University of Washington, Seattle, WA). Vector producer clones 
were generated under G418 selection (800 μg/ml) by transfection with the 
GP+E86 ecotropic packaging line44 (ProFection Mammalian Transfection 
Systems; Promega, Madison, WI). Virus titers were determined by serial 
dilution and transfer of G418 resistance to naive NIH-3T3 cells from 15 
producer clones for each construct. Genomic DNAs were analyzed for 
intact provirus and VCN by Southern blot. The absence of replication-
competent viruses was determined by a standard marker-rescue assay.45
Producer clones with the highest titers were used for the MEL 
cell transduction. Vector-containing supernatant was collected from 
semiconfluent GP+E86 producer clones and passed through a 0.45 µm 
filter.
Cell lines. The mouse fibroblast cell line NIH3T3, the packaging cell line 
GP+E86, and the adult-stage murine erythroleukemia cell line MEL58546 
were all maintained in Dulbecco’s modified Eagle’s medium (Gibco 
Invitrogen Life Science Technology, Grand Island, NY)  supplemented 
with 10% heat-inactivated fetal bovine serum (Gibco), 2 mmol/l 
l-glutamine (Gibco), 1 mmol/l sodium pyruvate (Gibco), 0.1 mmol/l 
 nonessential amino acids (Gibco) and the antibiotics penicillin/strepto-
mycin (10 μg/ ml) (Gibco) at 37 °C in the presence of 5% CO2.
MEL cell transduction. A total of 5 × 105 MEL cells were transduced at a 
modest multiplicity of infection in order to minimize provirus copy num-
ber by a 24-hour culture in vector-containing supernatant in the presence 
of 10 μg/ml polybrene (Sigma Chemical, St Louis, MO). The cells were 
then washed and plated in the absence of selection at a limiting dilution 
in 96-well flat-bottomed dishes. Individual clones were expanded and 
screened for the presence of vector and its expression. To study the extinc-
tion profile of the GFP-reporter gene, GFP+ cells were recovered by sorting 
(EPICS ALTRA HYPERSORT; Beckman Coulter, Miami, FL) 72 hrs after 
transduction, with the percentage of GFP+ cells measured twice a week by 
flow cytometer (FC-500; Beckman Coulter).
DNA analysis. To determine provirus integrity, genomic DNA was isolated 
by standard methods, and 10 µg was digested with the EcoRV restriction 
enzyme, which cuts once in each viral LTR. Southern-blot analysis was 
then performed using a P32-labeled 923 bp PstI fragment from the Neo 
gene as a probe. The full-length provirus band was 3,591 bp long for the 
MGPN2 vector, 4,053 bp for the sns5 (S) and sns5 (R) vectors, 3,856 bp 
for the sns (S) and sns (R) vectors, and 4,791 bp for the cHS4 vector. 
Using the same probe, the VCN/cell in individual clones was detected 
by digestion of genomic DNA with BamHI, which cuts once in the vec-
tor and generates a number of bands corresponding to the integration 
events. VCN/cell in pools was determined by digesting the DNA with 
EcoRV and BamHI and hybridizing the blot simultaneously with the 
Neo probe and with a 369 bp EcoRI fragment from the mouse β-globin 
locus εy as the other probe. The hybridization signals from the 3.33 kb 
provirus band and the 3.67 kb endogenous εy gene band were quantified 
with a PhosphoImager (Biorad GS525, Milano, Italy). To detect the pres-
ence of integrated vectors, multiplex PCR analysis was carried out using 
Neo gene specific oligos (5′-GCAAATCGGCTGCTCTGATG-3′ and 
5′-CTCGCTGGATGCGATGTTTC-3′) and oligos that were specific for 
mouse β-globin locus as a control (5′-TGACTCAGCAAACCCTAGGC-3′ 
and 5′-CTTTGTCCTACTGCTCTCATG-3′). Two PCR fragments, which 
were 350 bp from the Neo gene and 220 bp from mouse LCR hypersensitive 
site HS3, were generated. The double-copy configuration of the inserted 
DNA fragments was detected by PCR analysis using a GFP specific oli-
gonucleotide as reverse primer (5′-CTGAACTTGTGGCCGTTTA-3′) 
for all the constructs and different oligonucleotides as forward prim-
ers, which depended on the inserted sequence and orientation (SP3 
primer: 5′-GTCGATCATCCGATCTAATAT-3′, for sns and sns5 that are 
cloned in  forward orientation; SP20 primer: 5′-GACAACAACTACAA 
AACTGGAAT-3′, for sns and sns5 that are cloned in reverse orienta-
tion; cHS4 primer: 5′-AACATGCAGGCTCAGACACA-3′). Sequence 
analysis of the PCR products was carried out to confirm the fidelity of 
the  retrotransciption process (Genetic Analyzer ABI PRISMA 3130 XL; 
Applied Biosystems, Foster City, CA).
ChIP analysis. MEL cells that were transduced with the sns5 (S) vector 
were subcloned and screened for cells carrying transcriptionally active or 
inactive single-copy vectors. The ChIP assay was carried out as described 
elsewhere,47 with minor modifications. Briefly, protein-DNA crosslinking 
was performed by incubating 3 × 107 cells with 0.4% formaldehyde for 
10 minutes at room temperature. Soluble chromatin complex in 1 ml of 
NICaCl2 buffer (15 mmol/l Tris pH 7.5, 1 mmol/l CaCl2, 60 mmol/l KCl, 
0.5 mmol/l DTT, 15 mmol/l NaCl, 300 mmol/l sucrose) was produced by 
digestion with micrococcal nuclease from Staphylococcus aureus (Sigma 
Life Science, St Louis, MO) (1.5 U/ml) for 7 minutes at 37 °C. Under our 
conditions, the length of the digested chromatin ranged from 0.2 to 0.6 kb. 
To reduce the nonspecific background, the samples were incubated with 
100 μl of salmon sperm DNA/protein-A sepharose (Sigma Life Science) 
slurry for 1 hour at 4 °C with agitation. Twenty percent of chromatin that 
was cleared by centrifugation (input DNA) was withdrawn and processed 
as the immunoprecipitated chromatin. For each ChIP experiment, 25 μg 
of the DNA that contained chromatin was incubated in ChIP lysis  buffer 
(1% SDS, 10 mmol/l EDTA, 50 mmol/l Tris-HCl pH 8) overnight at 4 °C 
with 5 μg of each of the following antibodies anti-GATA1 (Santa Cruz 
Biotechnology, Santa Cruz, CA), anti-Oct1 (Santa Cruz Biotechnology), 
anti-MeCP2 (H300; Santa Cruz Biotechnology), anti-acetyl-histone H3 
(Lys9) (H3K9ac; Upstate, Charlottesville, VA), anti-thrimetyl-histone H3 
(Lys4) (H3K4me3; Upstate), anti-dimethyl-histone H3 (Lys 9) (H3K9me2; 
Upstate). The same chromatin aliquot was incubated with buffer only and 
used as negative control (no antibody). Five nanograms of the immu-
noprecipitated chromatin and of the input DNA, which was quanti-
fied using the Qubit fluorometer (Invitrogen Detection Technologies, 
Eugene, OR), were used for RT-PCR analysis (7,900 HT ABI PRISM; 
Applied Biosystem), with the following primers specific for sns5 and LTR 
sequences: sns5 forward: 5′-CCGGCAAATCAAGCTAAAGG-3′, sns5 
reverse: 5′-AGGGCCGTTGAGGTGTTG-3′, sns5 probe: 5′-TGCACT 
CGCAAACC-3′ LTR forward: 5′-CGCCCTCAGCAGTTTCTAGAGA-3′, 
LTR reverse: 5′-AAGGACCTGAAATGACCCTGTG-3′; and LTR probe: 
5′-CCATCAGATGTTTCCAGGGT-3′.
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